Ishizaka Y - Search Results

1

Long COVID: current status in Japan and knowledge about its molecular background.

Matsunaga A, Tsuzuki S, Morioka S, Ohmagari N, Ishizaka Y. Matsunaga A, et al. Among authors: ishizaka y. Glob Health Med. 2022 Apr 30;4(2):83-93. doi: 10.35772/ghm.2022.01013. Glob Health Med. 2022. PMID: 35586759 Free PMC article. Review.

2

Resveratrol blocks retrotransposition of LINE-1 through PPAR α and sirtuin-6.

Okudaira N, Ishizaka Y, Tamamori-Adachi M. Okudaira N, et al. Among authors: ishizaka y. Sci Rep. 2022 May 11;12(1):7772. doi: 10.1038/s41598-022-11761-0. Sci Rep. 2022. PMID: 35546166 Free PMC article.

3

A case report of breakthrough infection with the SARS-CoV-2 delta variant and household transmission: Role of vaccination, anti-spike IgG and neutralizing activity.

Moriyama Y, Ishikane M, Ueno M, Matsunaga A, Ishizaka Y, Arashiro T, Kanno T, Suzuki T, Kimura K. Moriyama Y, et al. Among authors: ishizaka y. J Infect Chemother. 2022 Jul;28(7):962-964. doi: 10.1016/j.jiac.2022.02.003. Epub 2022 Feb 11. J Infect Chemother. 2022. PMID: 35461768 Free PMC article.

4

Sex- and Age-related Differences in Spinal Degeneration: An Anatomical and Magnetic Resonance Imaging Study of the Human Spine.

Asai T, Sakuma E, Mizutani T, Ishizaka Y, Ori K, Ueki T. Asai T, et al. Among authors: ishizaka y. Prog Rehabil Med. 2022 Mar 5;7:20220011. doi: 10.2490/prm.20220011. eCollection 2022. Prog Rehabil Med. 2022. PMID: 35342836 Free PMC article.

5

Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants.

Ueno M, Iwata-Yoshikawa N, Matsunaga A, Okamura T, Saito S, Ashida S, Yoshida I, Nagashima M, Asakura H, Yaoita Y, Suzuki J, Sadamasu K, Yoshimura K, Kutsuna S, Shiwa-Sudo N, Nagata N, Suzuki T, Suzuki A, Okamoto M, Kimura M, Ohmagari N, Miura R, Ishizaka Y. Ueno M, et al. Among authors: ishizaka y. Antiviral Res. 2022 May;201:105297. doi: 10.1016/j.antiviral.2022.105297. Epub 2022 Mar 24. Antiviral Res. 2022. PMID: 35341809 Free PMC article.

6

Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection.

Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Iwamoto N, Ujiie M, Kutsuna S, Morioka S, Ishizaka Y, Mitsuya H, Ohmagari N. Inada M, et al. Among authors: ishizaka y. Int J Infect Dis. 2022 Jun;119:18-20. doi: 10.1016/j.ijid.2022.03.017. Epub 2022 Mar 16. Int J Infect Dis. 2022. PMID: 35306204 Free PMC article.

7

A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection.

Beppu H, Ogawa T, Ishikane M, Kawanishi T, Fukuda T, Sato L, Matsunaga A, Maeda K, Katagiri D, Ishizaka Y, Mitsuya H, Ohmagari N, Yasui F, Kohara M, Kikuchi K, Wakai S. Beppu H, et al. Among authors: ishizaka y. CEN Case Rep. 2022 Mar 9:1-6. doi: 10.1007/s13730-022-00697-z. Online ahead of print. CEN Case Rep. 2022. PMID: 35266095 Free PMC article.

8

Reversibly controlled infrared transparency of conjugated polymer films incorporated into a compact electrochemical cell structure.

Unuma T, Ishizaka Y. Unuma T, et al. Among authors: ishizaka y. Appl Opt. 2022 Jan 20;61(3):759-764. doi: 10.1364/AO.447806. Appl Opt. 2022. PMID: 35200781

9

Prolonged SARS-CoV-2 infection associated with long-term corticosteroid use in a patient with impaired B-cell immunity.

Morishita M, Suzuki M, Matsunaga A, Ishizhima K, Yamamoto T, Kuroda Y, Kanno T, Tsujimoto Y, Ishida A, Hashimoto M, Ishii S, Takasaki J, Naka G, Iikura M, Izumi S, Suzuki T, Maeda K, Ishizaka Y, Hojo M, Sugiyama H. Morishita M, et al. Among authors: ishizaka y. J Infect Chemother. 2022 Jul;28(7):971-974. doi: 10.1016/j.jiac.2022.02.006. Epub 2022 Feb 10. J Infect Chemother. 2022. PMID: 35184976 Free PMC article.

10

Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine.

Miyazato Y, Yamamoto K, Yamada G, Kubota S, Ishikane M, Sugiyama M, Ueno M, Matsunaga A, Miyoshi-Akiyama T, Ishizaka Y, Ohmagari N. Miyazato Y, et al. Among authors: ishizaka y. Emerg Infect Dis. 2022 Apr;28(4):870-872. doi: 10.3201/eid2804.212585. Epub 2022 Feb 11. Emerg Infect Dis. 2022. PMID: 35148495 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results